Previous Close | 30.76 |
Open | 30.69 |
Bid | 30.47 x 1100 |
Ask | 31.00 x 1200 |
Day's Range | 30.64 - 30.91 |
52 Week Range | 17.75 - 30.91 |
Volume | |
Avg. Volume | 769,253 |
Market Cap | 28.646B |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 12, 2022 |
1y Target Est | N/A |
Philips stroke solution Philips stroke solution September 10, 2024 Joint policy paper provides recommendations for effective policymaking and investments in stroke centers with specialized treatments to improve health outcomes and reduce costsTimely access to mechanical thrombectomy – a proven minimally invasive therapy to remove the blood clot that caused the stroke – has the potential to revolutionize treatment for major ischemic strokes, but the procedure remains the exception rather than the
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the Asia Pacific (APAC) findings of its Future Health Index (FHI) 2024 report: Better care for more people. The ninth edition of the report, which surveyed nearly 3,000 healthcare leaders in 14 countries, including Australia, Indonesia, and Singapore, shows that healthcare leaders are focusing on improving operational efficiencies through workflow prioritization, data integration, and AI-enabled innovation
Philips Azurion Carilion Cardiovascular Institute Philips Azurion EP August 20, 2024 Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AE